Fatigue and Cancer Treatment(FACT)- an Exercise Intervention

This study has been completed.
Sponsor:
Information provided by:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00181129
First received: September 12, 2005
Last updated: September 29, 2008
Last verified: September 2008
  Purpose

The purpose of this randomized controlled trial is to determine the effects of a nurse-directed, home-based walking exercise program to mitigate fatigue and maintain physical functioning during adjuvant therapy for cancer. The sample will be randomized into exercise (EX) or usual care (UC) groups. The independent study variable is participation in a walking exercise program. Outcomes include: fatigue, sleep disturbance, emotional distress, physical functioning and quality of life. The effects of the walking exercise program will be evaluated using self-report questionnaires administered pre- and post-treatment, patient diaries, and symptoms assessments at defined intervals during adjuvant therapy


Condition Intervention
Cancer,
Fatigue
Behavioral: home based self paced walking program

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Mitigating Cancer Treatment-Related Fatigue by Exercise

Resource links provided by NLM:


Further study details as provided by Johns Hopkins University:

Estimated Enrollment: 140
Study Start Date: September 2002
  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Confirmed diagnosis of cancer (Stage 1,2,or 3),

21 years of age or older,

Free of cognitive or physical deficits that would preclude entry into study,

not currently exercising 120 min/wk or more

Exclusion Criteria:

Concurrent major health problems or disabilities that would limit participation in an exercise program.

Stage 4 cancer (metastisis)

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00181129

Locations
United States, Maryland
Johns Hopkins University School of Nursing
Baltimore, Maryland, United States, 21205
Sponsors and Collaborators
Johns Hopkins University
Investigators
Principal Investigator: Victoria L Mock, DNSc Johns Hopkins University School of Nursing
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00181129     History of Changes
Other Study ID Numbers: NINR:RO1NRO4991
Study First Received: September 12, 2005
Last Updated: September 29, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by Johns Hopkins University:
Fatigue
Cancer treatment

Additional relevant MeSH terms:
Fatigue
Signs and Symptoms

ClinicalTrials.gov processed this record on July 22, 2014